Treatment interventions for Parkinson's disease: an evidence based assessment

被引:188
|
作者
Rascol, O [1 ]
Goetz, C
Koller, W
Poewe, W
Sampaio, C
机构
[1] Toulouse Univ Hosp, Clin Invest Ctr, F-31073 Toulouse, France
[2] Toulouse Univ Hosp, Dept Clin Pharmacol, INSERM, U455, F-31073 Toulouse, France
[3] Rush Presbyterian St Lukes Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA
[4] Univ Miami, Dept Neurol, Miami, FL 33152 USA
[5] Univ Innsbruck, Dept Neurol, A-6020 Innsbruck, Austria
[6] Fac Med Lisbon, Inst Pharmacol & Therapeut, Lisbon, Portugal
来源
LANCET | 2002年 / 359卷 / 9317期
关键词
D O I
10.1016/S0140-6736(02)08520-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We did a systematic review, with a uniform method of assessment of efficacy and safety, to assess the different interventions available for the management of Parkinson's disease (drugs, surgical interventions, and physical treatments) with respect to the following Indications: prevention of disease progression, symptomatic treatment of motor features (parkinsonism), symptomatic control of motor complications, prevention of motor complications, and symptomatic treatment of non-motor features. Our aim was not to define practice guidelines, but rather to improve clinicians' knowledge of the presently available published clinical evidence, based mainly on randomised controlled trials. We hope that our review will help doctors to incorporate this background into their own decision-making strategy to make appropriate choices with respect to the treatment of individual patients with Parkinson's disease.
引用
收藏
页码:1589 / 1598
页数:10
相关论文
共 50 条
  • [41] Assessment of patients with Parkinson's disease based on federated learning
    Guan, Bo
    Yu, Lei
    Li, Yang
    Jia, Zhongwei
    Jin, Zhen
    INTERNATIONAL JOURNAL OF MACHINE LEARNING AND CYBERNETICS, 2024, 15 (04) : 1621 - 1632
  • [42] Assessment of Parkinson's Disease Based on Deep Neural Networks
    Tagaris, Athanasios
    Kollias, Dimitrios
    Stafylopatis, Andreas
    ENGINEERING APPLICATIONS OF NEURAL NETWORKS, EANN 2017, 2017, 744 : 391 - 403
  • [43] The Evidence for Disease Modification in Parkinson's Disease
    Lew, Mark F.
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2011, 121 : 18 - 26
  • [44] Home-Based Monitoring and Assessment of Parkinson's Disease
    Cunningham, L.
    Mason, S.
    Nugent, C.
    Moore, G.
    Finlay, D.
    Craig, D.
    IEEE TRANSACTIONS ON INFORMATION TECHNOLOGY IN BIOMEDICINE, 2011, 15 (01): : 47 - 53
  • [45] Assessment of patients with Parkinson’s disease based on federated learning
    Bo Guan
    Lei Yu
    Yang Li
    Zhongwei Jia
    Zhen Jin
    International Journal of Machine Learning and Cybernetics, 2024, 15 : 1621 - 1632
  • [46] Preclinical assessment of a pluripotent cell therapy for treatment of Parkinson's Disease
    Kirkeby, A.
    TOXICOLOGY LETTERS, 2021, 350 : S37 - S37
  • [47] An assessment of Parkinson's disease medication treatment patterns in the Medicaid population
    Johnsrud, Michael
    Richards, Kristin
    Arcona, Steve
    Sasane, Rahul
    Leoni, Matthew
    CLINICAL PARKINSONISM & RELATED DISORDERS, 2021, 5
  • [48] Objective Automatic Assessment of Rehabilitative Speech Treatment in Parkinson's Disease
    Tsanas, Athanasios
    Little, Max A.
    Fox, Cynthia
    Ramig, Lorraine O.
    IEEE TRANSACTIONS ON NEURAL SYSTEMS AND REHABILITATION ENGINEERING, 2014, 22 (01) : 181 - 190
  • [49] Treatment of Parkinson's disease
    Bergus, G
    JOURNAL OF FAMILY PRACTICE, 1996, 42 (05): : 457 - 458
  • [50] Treatment of Parkinson's disease
    不详
    NEUROLOGICAL SCIENCES, 2003, 24 (Suppl 3) : S165 - S213